New guidance from the Office of Drug and Alcohol Policy and Compliance (ODAPC) on behalf of each DOT Agency has been issued, impacting the process for converting federally regulated drug tests to non-regulated status. Below, we detail these updated procedures and their implications for our clients and Medical Review Officers (MROs).